Verastem rides rally to snap up $52M in public offering

Verastem ($VSTM) has capitalized on the soaring value of its shares over the past month and raised $51.9 million from the sale of 3.7 million shares of common stock for $15 per share. Like many biotech companies, The Cambridge, MA-based cancer drug developer, whose shares had slumped after its IPO early last year, has seen its share price spike in recent weeks amid mounting interest in the sector from public investors. Shares of Verastem had climbed more than 78% this year through this morning, according to Google Finance. Article